US Stock MarketDetailed Quotes

TELO Telomir Pharmaceuticals

Watchlist

4.050
-0.060-1.46%

Close Mar 4 16:00 ET

4.050
0.0000.00%

Post 20:01 ET

120.54MMarket Cap-7.30P/E (TTM)

Telomir Pharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Telomir Pharmaceuticals Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 1 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual

Estimate

Date	Period	Revenue/Estimate	Earnings Call
--	2025/Q2	-- / 0.000	--
--	2025/Q1	-- / 0.000	--
--	2024/Q4	0.000 / 0.000	--

DatePeriodRevenue/EstimateEarnings Call

--2025/Q2-- / 0.000--

--2025/Q1-- / 0.000--

--2024/Q40.000 / 0.000--

--------

Unlock Free Earnings Estimates

Open Account

Telomir Pharmaceuticals Earnings Reports

Telomir Pharmaceuticals | 10-K: FY2024 Annual Report

Feb 4 07:29 ET

Telomir Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

Nov 12, 2024 16:50 ET

Telomir Pharmaceuticals | 10-Q: Q2 2024 Earnings Report

Aug 13, 2024 16:09 ET

Telomir Pharmaceuticals | 10-Q: Quarterly report

May 13, 2024 16:36 ET